COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices
This webinar was previously recorded on May 13th, 2020 and is now available on demand.
Join colleagues and thought leaders as we examine the emotional and logistical impact of COVID-19 on employees. Panelists will discuss job loss, mental wellbeing, employee’s top concerns and communication surrounding the global coronavirus pandemic.
Experts will discuss ways to offset anxiety and depression, steps to take care of your emotional well-being and logistical challenges such as homeschooling and balancing the ever-changing priorities during this crisis. There will also be discussion surrounding manager communication strategies, what works, what does not work and ways employers can calm employee’s fears during the pandemic.
Moderator
- Brandon Thompson
(Co-Founder, Careers in Aesthetics & Co-Founder & CEO, BNB Aesthetic Innovations)
Faculty
- Richard G. Fried, MD, PhD
(Board Certified Dermatologist & Clinical Psychologist, Clinical Director, Yardley Dermatology Associates) - John Connors
(CEO & President, Jan Marini Skin Research) - Mark Wilkins
(Executive Vice President and U.S. General Manager, Prollenium Medical Technologies) - Aaron Burton
(CEO, Sciton) - Jenna Mons Anderson
(CEO, AccessElite)
You May Also Like
Bensal HP Treatment for Burn and Excision Wounds: An In-Vivo Assessment of Wound Healing Efficacy and Immunological Impact
Bensal HP Treatment for Burn and Excision Wounds: An In-Vivo Assessment of Wound Healing Efficacy and Immunological Impact
Wound Care Is Trending: A JDD Vault Pick on Bensal HP and Repair This is a must-read article from JDD. Wound care is a hot topic in dermatology and that is…
Dermatology Roundup: New Regimen and Label Expansion in Inflammatory Skin Disease Treatments
Dermatology Roundup: New Regimen and Label Expansion in Inflammatory Skin Disease Treatments
The U.S. Food & Drug Administration (FDA) recently adopted changes to the approvals of two medications for inflammatory skin diseases. Ebglyss (lebrikizumab-lbkz) has a newly approved regimen of one maintenance…
From Endpoint to Exam Room: Understanding What Psoriasis Trials Really Tell Us
From Endpoint to Exam Room: Understanding What Psoriasis Trials Really Tell Us
Not all psoriasis data tell the same story, and sometimes the loudest signal isn't the most important one. In this episode of the JDD Podcast, host Dr. Adam Friedman sits…
